Highest-materiality recent filing
Thomas Sweeney resigned as CFO effective Oct 29, 2025, to pursue other opportunities; no disagreement with Board or management.
Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as independent director
Appointed Oct 17, 2025 as Class II director on audit, nominating, and compensation committees; deemed independent under Nasdaq and Rule 10A-3.
Oaktree Acquisition Corp. III Life Sciences CFO resigns; Thomas Sweeney appointed CFO
Courtney Conigliaro resigned as CFO effective June 3, 2025; resignation not due to any disagreements.
On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
Max materiality 0.50 · Median 0.50 · Most common event leadership